A Prognostic Score for Patients with Acute Leukemia or Myelodysplastic Syndromes Undergoing Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1, 2008, Pages 28-35

  Armand, Philippe ^a   Kim, Haesook T ^a   Cutler, Corey S ^a   Ho, Vincent T ^a   Koreth, John ^a   Ritz, Jerome ^a   Alyea, Edwin P ^a   Antin, Joseph H ^a   Soiffer, Robert J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Allogeneic stem cell transplantation; Cytogenetics; Iron overload; Myelodysplastic syndrome

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; FERRITIN; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOGENETICS; FEMALE; FERRITIN BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INDIVIDUALIZATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OUTCOMES RESEARCH; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL TIME; TREATMENT OUTCOME; VALIDATION STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CYTOGENETIC ANALYSIS; DISEASE-FREE SURVIVAL; FEMALE; FERRITINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, HOMOLOGOUS;

EID: 37349052778     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.07.016     Document Type: Article

References (32)

1. Cornelissen J.J., and Lowenberg B. Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program (2005) 151-155
2. Popat U., Carrum G., and Heslop H.E. Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia. Cancer Treat Rev 29 (2003) 3-10
3. Deeg H.J. Optimization of transplant regimens for patients with myelodysplastic syndrome (MDS). Hematology Am Soc Hematol Educ Program (2005) 167-173
4. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329 (1993) 987-994
5. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
6. Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106 (2005) 2912-2919
7. Artz A.S., Pollyea D.A., Kocherginsky M., et al. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 12 (2006) 954-964
8. Parimon T., Au D.H., Martin P.J., and Chien J.W. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 144 (2006) 407-414
9. Gratwohl A., Hermans J., Goldman J.M., et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 352 (1998) 1087-1092
10. CIBMTR Progress Report, January-December 2006.
11. Appelbaum F.R., and Anderson J. Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score. Leukemia 12 Suppl 1 (1998) S25-S29
12. Rubio S., Martins C., Lacerda J.F., Carmo J.A., Lourenco F., and Lacerda J.M. Allogeneic stem cell transplantation in patients with myelodysplastic syndrome: outcome analysis according to the International Prognostic Scoring System. Acta Med Port 19 (2006) 343-347
13. Armand P., Kim H.T., Cutler C.S., et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109 (2007) 4586-4588
14. Grimwade D., Walker H., Oliver F., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 (1998) 2322-2333
15. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1140-1154
16. Grambsch P., and Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
17. Harrell Jr. F.E., Lee K.L., Califf R.M., Pryor D.B., and Rosati R.A. Regression modelling strategies for improved prognostic prediction. Stat Med 3 (1984) 143-152
18. Armand P., Kim H.T., DeAngelo D.J., et al. Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation. Biol Blood Marrow Transplant 13 (2007) 655-664
19. Moorman A.V., Harrison C.J., Buck G.A., et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109 (2007) 3189-3197
20. Gomez-Nunez M., Martino R., Caballero M.D., et al. Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial. Bone Marrow Transplant 33 (2004) 477-482
21. Anderson J.E., Appelbaum F.R., Schoch G., et al. Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. Blood 87 (1996) 51-58
22. Ringden O., Horowitz M.M., Gale R.P., et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 270 (1993) 57-60
23. Cahn J.Y., Labopin M., Schattenberg A., et al. Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia 11 (1997) 416-419
24. Deeg H.J., Shulman H.M., Anderson J.E., et al. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. Blood 95 (2000) 1188-1194
25. Deeg H.J., and Guardiola P. Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis. Int J Hematol 76 Suppl 2 (2002) 29-34
26. Altes A., Remacha A.F., Sureda A., et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 29 (2002) 987-989
27. Ferrant A., Labopin M., Frassoni F., et al. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood 90 (1997) 2931-2938
28. Gale R.P., Horowitz M.M., Weiner R.S., et al. Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 16 (1995) 203-208
29. Kim D.H., Sohn S.K., Kim J.G., et al. Parameters for predicting allogeneic PBSCT outcome of acute myeloid leukemia: cytogenetics at presentation versus disease status at transplantation. Ann Hematol 84 (2005) 25-32
30. Ogawa H., Ikegame K., Kawakami M., et al. Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation. Int J Hematol 79 (2004) 495-500
31. Nevill T.J., Fung H.C., Shepherd J.D., et al. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood 92 (1998) 1910-1917
32. Mrozek K., Marcucci G., Paschka P., Whitman S.P., and Bloomfield C.D. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?. Blood 109 (2007) 431-448